Sort
51,593 grants matching “hepatitis”
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
$548,355Hao Zhu · Ut Southwestern Medical Center · R01 · FY2024 · AA
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
$548,355Hao Zhu · Ut Southwestern Medical Center · R01 · FY2023 · AA
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
$548,355Hao Zhu · Ut Southwestern Medical Center · R01 · FY2022 · AA
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
$548,355Hao Zhu · Ut Southwestern Medical Center · R01 · FY2025 · AA
Phospholipid-Mediated Metabolic Control in the Liver
$548,345David E Cohen · Brigham And Women'S Hospital · R01 · FY2015 · DK
Oral digoxin for the treatment of NASH
$548,339Bubu Ama Banini · Yale University · R01 · FY2025 · DK
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$548,337Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A Novel Stem Cell-based Approach for Generating Non-Human Primate Livers in Pigs
$548,335Clifford J. Steer · University Of Minnesota · R01 · FY2019 · DK
A Novel Stem Cell-based Approach for Generating Non-Human Primate Livers in Pigs
$548,335Clifford J. Steer · University Of Minnesota · R01 · FY2020 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B
$548,297Jody L Baron · University Of California, San Francisco · R01 · FY2021 · AI
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASH
$548,258Lei Yin · University Of Michigan At Ann Arbor · R01 · FY2024 · DK
SF1 neurons and sympathetic regulation of glucose homeostasis
$548,091Joel K Elmquist · Ut Southwestern Medical Center · R01 · FY2024 · DK
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
$548,077Hao Zhu · Ut Southwestern Medical Center · R01 · FY2021 · AA
Stem Cell-Based In vivo Models of Human Genetic Liver Diseases
$548,072Gary A Peltz · Stanford University · R01 · FY2016 · DK
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease
$548,069David A Rudnick · Washington University · R01 · FY2025 · DK
GENETIC REGULATION OF IGF-I IN PEAK BONE DENSITY OF MICE
$548,069Clifford J Rosen · Jackson Laboratory · R01 · FY2007 · AR
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis
$548,064Jennifer Y. Chen · University Of California, San Francisco · R01 · FY2024 · DK
A Web-Based Smoking Intervention for Cancer Survivors
$547,992Karen M Emmons · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Stem Cell-Based In vivo Models of Human Genetic Liver Diseases
$547,988Gary A Peltz · Stanford University · R01 · FY2017 · DK
Recellularization of Liver Bioscaffolds
$547,901Martin L Yarmush · Massachusetts General Hospital · R01 · FY2012 · DK
Buprenorphine for Prisoners
$547,897Timothy W Kinlock · Friends Research Institute, Inc. · R01 · FY2009 · DA
HIV Vaccine Trials in Women
$547,879New York Blood Center · R01 · FY2004 · DA
Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission
$547,877Julia B Dickson-Gomez · Medical College Of Wisconsin · R01 · FY2021 · DA
Coactivator P300 promotes hepatic steatosis in obesity
$547,859Ling He · Johns Hopkins University · R01 · FY2020 · DK
Beyond Boundaries: ELSI and the Complex Relationships between Infectious and Genetic Diseases
$547,847Gail Geller · Johns Hopkins University · RM1 · FY2020 · HG